TTK Healthcare Limited (BOM:507747)
India · Delayed Price · Currency is INR 1,048.35
-34.35 (-3.17%)
At close: Jul 28, 2026
TTK Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 15,299 | 10,466 | 16,915 | 20,956 | 14,611 | 11,715 | |
Market Cap Growth | -16.46% | -38.13% | -19.28% | 43.43% | 24.71% | 67.63% |
Enterprise Value | 6,180 | 4,725 | 9,299 | 12,755 | 5,327 | 9,299 |
Last Close Price | 1082.70 | 733.15 | 1176.17 | 1446.88 | 1001.07 | 793.15 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 23.29 | 15.93 | 20.72 | 33.35 | 2.28 | 28.17 |
PS Ratio | 1.78 | 1.22 | 2.11 | 2.78 | 2.02 | 1.96 |
PB Ratio | 1.37 | 0.94 | 1.59 | 2.09 | 1.53 | 3.55 |
P/TBV Ratio | 1.37 | 0.94 | 1.59 | 2.09 | 1.53 | 3.56 |
P/FCF Ratio | - | - | - | - | - | 29.67 |
P/OCF Ratio | - | - | - | - | - | 26.04 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.72 | 0.55 | 1.16 | 1.69 | 0.74 | 1.55 |
EV/EBITDA Ratio | 23.60 | 18.57 | 32.85 | 34.74 | 16.94 | 42.66 |
EV/EBIT Ratio | 35.47 | 27.12 | 45.00 | 52.23 | 28.51 | 100.19 |
EV/FCF Ratio | - | - | - | - | - | 23.55 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.07 |
Debt / EBITDA Ratio | 0.93 | 0.93 | 0.84 | 0.61 | 0.87 | 1.02 |
Debt / FCF Ratio | - | - | - | - | - | 0.56 |
Net Debt / Equity Ratio | -0.82 | -0.82 | -0.78 | -0.82 | -0.86 | -0.76 |
Net Debt / EBITDA Ratio | -35.83 | -35.83 | -29.35 | -22.40 | -26.06 | -11.50 |
Net Debt / FCF Ratio | 33.84 | 33.84 | 49.41 | 53.66 | 22.44 | -6.35 |
Asset Turnover | 0.66 | 0.66 | 0.64 | 0.63 | 0.84 | 1.14 |
Inventory Turnover | 3.91 | 3.91 | 3.86 | 3.92 | 4.44 | 3.90 |
Quick Ratio | 5.25 | 5.25 | 4.64 | 4.76 | 4.56 | 1.50 |
Current Ratio | 5.91 | 5.91 | 5.23 | 5.35 | 5.06 | 2.03 |
Return on Equity (ROE) | 6.03% | 6.03% | 7.90% | 6.43% | 6.96% | 5.93% |
Return on Assets (ROA) | 0.83% | 0.83% | 1.04% | 1.29% | 1.35% | 1.10% |
Return on Invested Capital (ROIC) | 3.88% | 6.34% | 7.55% | 11.67% | 12.72% | 8.35% |
Return on Capital Employed (ROCE) | 1.60% | 1.60% | 1.90% | 2.40% | 1.90% | 2.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.29% | 6.28% | 4.83% | 3.00% | 43.78% | 3.55% |
FCF Yield | -1.76% | -2.57% | -0.99% | -0.73% | -2.50% | 3.37% |
Dividend Yield | 0.95% | 1.36% | 0.85% | 0.69% | 1.00% | 1.26% |
Payout Ratio | 21.51% | 21.51% | 17.30% | 22.48% | 2.21% | 20.39% |
Total Shareholder Return | 0.95% | 1.36% | 0.85% | 0.69% | 1.00% | 1.26% |